Accuitis, Inc.

Accuitis, Inc. We are a pharmaceutical company with first in class therapeutics for underserved diseases

Wishing all of our board, investors, consultants, and partners a Happy Holiday and a prosperous new year from the founde...
11/21/2022

Wishing all of our board, investors, consultants, and partners a Happy Holiday and a prosperous new year from the founders of Accuitis, Inc. 2023 should be a very exciting year!

Congratulations to our Chief Science officer Dr. Jack Arbiser for another peer reviewed publication highlighting the the...
05/26/2020

Congratulations to our Chief Science officer Dr. Jack Arbiser for another peer reviewed publication highlighting the therapeutic potential of once of our licensed compounds Honokiol Bis-Dichloroacetate:

We have identified a selective TRAP1 inhibitor that can be used to better dissect TRAP1 biochemical functions and to tailor novel tumor-targeting strategies.

Address

Cu***ng, GA

Alerts

Be the first to know and let us send you an email when Accuitis, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Accuitis, Inc.:

Share